In view of the economic environment, Novozymes considers its current 2009 growth outlook satisfactory. The slowdown in 4Q 2008 is not considered a reliable indicator of 2009 full-year performance. Sales growth is forecast at 8-13% (in terms of DKR), and operating profit is expected to grow by 10-15%
โฆ LIBER โฆ
Novozymes 2008: outlook 2009
- Publisher
- Elsevier Science
- Year
- 2009
- Weight
- 61 KB
- Volume
- 2009
- Category
- Article
- ISSN
- 1351-4210
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Novozymes 2008: outlook 2009
๐
Article
๐
2009
๐
Elsevier Science
โ 59 KB
Novozymes 1H 2009: outlook for 2009
๐
Article
๐
2009
๐
Elsevier Science
โ 62 KB
Novozymes 1H 2010: 2010 outlook
๐
Article
๐
2010
๐
Elsevier Science
โ 65 KB
Novozymes 1Q 2009
๐
Article
๐
2009
๐
Elsevier Science
โ 63 KB
Novecare provides high-performance products and solutions to a wide range of industries including cosmetics, detergents, agrochemicals and oil, as well as industrial applications. Novecare's Home & Personal Care and Agro segments demonstrated resilience while Oilfield and Industrial applications exp
Novozymes 1H 2009
๐
Article
๐
2009
๐
Elsevier Science
โ 70 KB
Novozymes 2008: key figures
๐
Article
๐
2009
๐
Elsevier Science
โ 68 KB
applications for automobiles, ITrelated products, civil engineering and construction works falling due to the global economic downturn triggered by the US financial crisis. The surfactant market, however, is forecast to remain stable as applications for daily commodities such as soap, shampoos, and